Aptevo Therapeutics (APVO) Earnings Date & Reports

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

APVO is expected to report earnings to -619 cents per share on August 06

Aptevo Therapeutics APVO Stock Earnings Reports

Q2'26

Est.

$-6.20

Q4'25

Missed

by $2.49

Q3'25

Beat

by $1.55

Q2'25

Missed

by $8.15

Q1'25

Missed

by $4.11

The last earnings report on March 26 showed earnings per share of -623 cents, missing the estimate of -374 cents. With 2.13K shares outstanding, the current market capitalization sits at 5.97M.

View a ticker or compare two or three

Compare

APVO

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for APVO